Keywords: Takeda. Asterllas, Market leaders, Japan, R&D pipelines, Sales forecasts, Decision Resources

Takeda's leadership as Japan's largest drugmaker set to decline, says DR

Article | 29 October 2012

Based on full-year 2011 sales, Japan’s Takeda Pharmaceutical (TYO: 4502) maintained its position as the largest Japanese pharmaceutical company, with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in